Overall, this study illustrates the AD-protective effects of the R136S mutation against APOE4-promoted pathologies in a gene dose-dependent manner, both in vivo in a tauopathy mouse model and in vitro in hiPSC-derived neurons (Supplementary Fig. 9). The gene discussed is APOE; the disease is Alzheimer disease.